selected publications
- Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set. Blood. 2020 Academic Article GET IT
- Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma. Blood. 2020 Academic Article GET IT
- Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma. Blood advances. 2020 Academic Article GET IT
- Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy. The American journal of surgical pathology. 2020 Academic Article GET IT
- The gift that keeps on giving: lenalidomide maintenance after second autologous stem cell transplant in multiple myeloma. Leukemia & lymphoma. 2020 Academic Article GET IT
- Plasma Cell Myeloma Presenting With Amyloid-Laden Crystal-Negative Histiocytosis. American journal of clinical pathology. 2020 Academic Article GET IT
- COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers. medRxiv : the preprint server for health sciences. 2020 Article GET IT
-
Kidney transplantation in AL Amyloidosis: is it time to maximize access?.
British journal of haematology.
2019
Letter
GET IT
Times cited: 5 -
Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.
British journal of haematology.
2019
Academic Article
GET IT
Times cited: 20 -
Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
British journal of haematology.
2019
Academic Article
GET IT
Times cited: 3 -
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma.
British journal of haematology.
2018
Academic Article
GET IT
Times cited: 16 -
Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study.
British journal of haematology.
2018
Academic Article
GET IT
Times cited: 17 -
Evolving strategies in the initial treatment of multiple myeloma.
Seminars in oncology.
2013
Academic Article
GET IT
Times cited: 3 -
A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma.
Journal for immunotherapy of cancer.
2013
Academic Article
GET IT
Times cited: 19 -
Lenalidomide after stem-cell transplantation for multiple myeloma.
The New England journal of medicine.
2012
Academic Article
GET IT
Times cited: 788 -
Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2008
Academic Article
GET IT
Times cited: 13